NARSOPLIMAB

UNII:	FT24ZQQ5RP
Formula:
Preferred Substance Name:	NARSOPLIMAB
GSRS Full Record:	FT24ZQQ5RP i

2108782-45-0
ANTI-MASP-2 MONOCLONAL ANTIBODY OMS721
IMMUNOGLOBULIN G4 (226-PROLINE), ANTI-(HUMAN MANNAN-BINDING LECTIN-ASSOCIATED SERINE PROTEASE 2) (HUMAN MONOCLONAL OMS721 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL OMS721 .LAMBDA.-CHAIN, DIMER
IMMUNOGLOBULIN G4-LAMBDA, ANTI-(HOMO SAPIENS MANNAN-BINDING LECTIN SERINE PROTEASE 2 (MANNOSE-BINDING PROTEIN-ASSOCIATED SERINE PROTEASE 2, EC=3.4.21.104) HUMAN MONOCLONAL ANTIBODY .GAMMA.4 HEAVY CHAIN (1-445) (HOMO SAPIENS VH (IGHV2-26*01 (94%) (IGHD)-IGHJ4*01) (10.7.10) (1-118) -HOMO SAPIENS IGHG4*01 (HINGE(S10>P(226))) (119-445)) (132-211')-DISULFIDE WITH .LAMBDA. LIGHT CHAIN (1'-212') (HOMO SAPIENS V-LAMBDA (IGLV3-1*01 (94%) IGLJ2*01)(6.3.9) (1'-106') -HOMO SAPIENS IGLC2*01 (107'-212')), DIMER (224-224'':227-227'')-BISDISULFIDE
MASP-2 ANTIBODY
NARSOPLIMAB [INN]
NARSOPLIMAB [USAN]
NARSOPLIMAB [WHO-DD]
NARSOPLIMAB-WUUG
OMS00620646
OMS620646
OMS721
OMS-721
YARTEMLEA

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

NARSOPLIMAB

Synonyms and Mappings

Resources